Why are combination inhalers prescribed?

Combination inhalers are prescribed primarily to provide synergistic effects for better control of asthma and chronic obstructive pulmonary disease (COPD). These inhalers typically contain a combination of a corticosteroid and a long-acting beta-agonist or other bronchodilator. The corticosteroid helps reduce inflammation in the airways, while the bronchodilator works to open airways and improve airflow. By using both types of medication in one inhaler, patients can benefit from the complementary mechanisms of action. This combination not only enhances overall control of symptoms and reduces the frequency of exacerbations but also improves patient adherence because it simplifies the medication regimen.

Other options do not capture the main therapeutic goal of combination inhalers. Increasing side effects is not a goal of prescribing medications; rather, the aim is to maximize efficacy while minimizing adverse effects. Although combination inhalers may potentially limit overall medication costs by combining medications into one inhaler, this is not the primary reason for their use. Additionally, while some combination inhalers may reduce the frequency of administration compared to using multiple separate inhalers, the primary benefit lies in the synergistic effects they provide for more effective symptom management.